Walking test with a portable device for neuromuscular disease
Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital clinical trials.
This study tests a portable device that analyzes walking without markers. It aims to see if it can help assess walking in people with neuromuscular diseases and healthy volunteers, which could lead to simpler check-ups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You can walk without help from another person.
- You are willing to sign a consent form to join the study.
- You have health insurance through the social security system.
- If you have a neuromuscular disease, you can walk for 2 minutes without help, stand up from a chair 3 times in 30 seconds, and have a confirmed genetic diagnosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study watches how people with certain muscle or nerve diseases walk over time. It may help doctors understand changes in walking patterns and is open to adults who can walk and have a genetic diagnosis of a neuromuscular condition.
This study uses wearable devices (like smartwatches or activity trackers) to monitor movement and motor development in young children with spinal muscular atrophy (SMA), a rare genetic condition affecting muscle strength. The goal is to see if wearables can track disease progression and treatment response better than traditional clinic visits.
This study uses motion analysis to understand walking and arm function in adults with certain neurological or metabolic diseases. The goal is to find patterns that help doctors better manage these conditions.
This study looks at how children and teens with Duchenne muscular dystrophy (DMD) or spinal muscular atrophy (SMA) walk, by having them do walking tests while wearing sensors. The goal is to find better ways to track how these diseases progress and how treatments work over time, without needing blood tests or scans.
This study watches how much you move around at home using a small wearable sensor if you have CMT1A, a genetic nerve condition that affects walking. Researchers want to understand daily activity patterns to better support patients with this condition.
This study checks how well commercially available wearable sensors (IMUs) can measure walking problems during a clinic gait analysis. It may help your care team get more accurate information about your walking patterns, falls risk, and fatigue during walking.
Hear when a new Charcot-Marie-Tooth trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.